BioInformant is honored to be a sponsor for the upcoming “Biorepositories and Sample Management Summit” in Boston, Massachussetts, over October 12-14, 2015. This 3-day event promises to be the most interactive biobanking community event of the year.
The 8th Annual Biorepositories and Sample Management Conference will examine the industry’s most pressing topics, benchmark best practices with your peers and ultimately learn how to maximize the value of your biospecimens through quality-driven biobanking.
This year, the theme is quality, and how the quality of your samples can determine whether you will be forced to repeat clinical trials or reproduce their results as well as the potential fallout from adverse situations. Given the diversity of biobanks in the US, from academic institutions to research institutes and hospitals, any efforts at creating regulations or governing rules for them will require more than a “one-size-fits-all” model.
This event will feature numerous speakers, all of whom can be found here.
Key topics will be explored through case studies and sessions on quality biobanking, ranging from next-gen sequencing to management of biosample data. This peer-exchange event will be attended by 150+ sample management leaders and the growing community of biobankers, including global stakeholders from pharma, biotech, biorepositories, large academia, government, hospitals and research centers.
To learn more, view full program details for the “Biorepositories and Sample Management Summit.” If you’re ready to attend, use the code “XP2098BioInform” to get 15% off your Event Pass, a special offer only for BioInformant readers!
Want to be better informed than your competition? Get future stem cell industry updates.
BioInformant is the only research firm that has served the stem cell sector since it emerged. Our management team comes from a BioInformatics background – the science of collecting and analyzing complex genetic codes – and applies these techniques to the field of market research. BioInformant has been featured on news outlets including the Wall Street Journal, Nature Biotechnology, CBS News, Medical Ethics, and the Center for BioNetworking. Serving Fortune 500 leaders that include GE Healthcare, Pfizer, Goldman Sachs, Becton Dickinson, and Thermo Fisher Scientific, BioInformant is your global leader in stem cell industry data.
Click here to view our global strategic reports for the stem cell and cord blood industry.